These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 30988043)

  • 21. The value of methotrexate in dermatomyositis.
    Zieglschmid-Adams ME; Pandya A; Cohen SB; Sontheimer RD
    J Am Acad Dermatol; 1998 Jan; 38(1):130-2. PubMed ID: 9448226
    [No Abstract]   [Full Text] [Related]  

  • 22. Favorable response of metastatic osteogenic sarcoma to pulse high-dose methotrexate with citrovorum rescue and radiation therapy.
    Jaffe N; Paed D; Farber S; Traggis D; Geiser C; Kim BS; Das L; Frauenberger G; Djerassi I; Cassady JR
    Cancer; 1973 Jun; 31(6):1367-73. PubMed ID: 4541163
    [No Abstract]   [Full Text] [Related]  

  • 23. [Pancytopenia in rheumatoid arthritis treated with methotrexate].
    Laroche F; Perrot S; Menkès CJ
    Presse Med; 1996 Sep; 25(25):1144-6. PubMed ID: 8949606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Folate supplementation and methotrexate.
    Dijkmans BA
    Br J Rheumatol; 1995 Dec; 34(12):1172-4. PubMed ID: 8608361
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Folic and folinic acid supplementation reduces methotrexate gastrointestinal side effects in rheumatoid arthritis.
    Pincus T
    Clin Exp Rheumatol; 1998; 16(6):667-8. PubMed ID: 9844757
    [No Abstract]   [Full Text] [Related]  

  • 26. Folic acid or folinic acid for reducing side effects of methotrexate for people with rheumatoid arthritis.
    Shea B
    J Evid Based Med; 2013 Aug; 6(3):202-3. PubMed ID: 24325380
    [No Abstract]   [Full Text] [Related]  

  • 27. [Acute toxicity of high doses of methotrexate in treatment of ALL in children: a case study].
    Periáñez-Párraga L; Pérez-Rodríguez O; do Pazo-Oubiña F; Crespí-Monjo M
    Farm Hosp; 2009; 33(3):172-3. PubMed ID: 19712601
    [No Abstract]   [Full Text] [Related]  

  • 28. Idiosyncratic reaction to low dose methotrexate resulting in pancytopenia and cutaneous toxicity.
    Rajsekhar L; Chakravathy MS; Prasad AK; Srinivasan VR
    J Assoc Physicians India; 2002 Jun; 50():851-2. PubMed ID: 12240864
    [No Abstract]   [Full Text] [Related]  

  • 29. Methotrexate in psoriasis with and without leucovorin: effect of different dosage schedules on acute liver toxicity.
    Zachariae H; Bjerring P
    Acta Derm Venereol; 1982; 62(5):446-8. PubMed ID: 6183902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pancytopenia induced by low-dose methotrexate. A study of the cases reported to the Finnish Adverse Drug Reaction Register From 1991 to 1999.
    Kuitunen T; Malmström J; Palva E; Pettersson T
    Scand J Rheumatol; 2005; 34(3):238-41. PubMed ID: 16134732
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does folate supplementation make sense in patients with rheumatoid arthritis treated with methotrexate?
    Stenger AA; Houtman PM; Bruyn GA
    Ann Rheum Dis; 1992 Aug; 51(8):1019-20. PubMed ID: 1306658
    [No Abstract]   [Full Text] [Related]  

  • 32. Methotrexate with citrovorum factor rescue for gestational trophoblastic neoplasms.
    Goldstein DP; Saracco P; Osathanondh R; Goldstein PR; Marean AR; Bernstein MR
    Obstet Gynecol; 1978 Jan; 51(1):93-6. PubMed ID: 201893
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methotrexate in rheumatoid arthritis.
    Furst DE; Kremer JM
    Arthritis Rheum; 1988 Mar; 31(3):305-14. PubMed ID: 2965875
    [No Abstract]   [Full Text] [Related]  

  • 34. Methotrexate-Induced Pancytopenia and Mucositis Caused by Medication Error.
    Amissah-Arthur MB; Baah W
    Ghana Med J; 2020 Mar; 54(1):68-71. PubMed ID: 32863415
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pancytopenia induced by low-dose methotrexate for rheumatoid arthritis.
    Kevat SG; Hill WR; McCarthy PJ; Ahern MJ
    Aust N Z J Med; 1988 Aug; 18(5):697-700. PubMed ID: 3245825
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of plasma pharmacokinetics to predict and prevent methotrexate toxicity.
    Stoller RG; Hande KR; Jacobs SA; Rosenberg SA; Chabner BA
    N Engl J Med; 1977 Sep; 297(12):630-4. PubMed ID: 302412
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early-onset pancytopenia and skin ulcer following low-dose methotrexate therapy.
    Hocaoglu N; Atilla R; Onen F; Tuncok Y
    Hum Exp Toxicol; 2008 Jul; 27(7):585-9. PubMed ID: 18829735
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Folate supplementation reduces the side effects of methotrexate therapy for psoriasis.
    Baran W; Batycka-Baran A; Zychowska M; Bieniek A; Szepietowski JC
    Expert Opin Drug Saf; 2014 Aug; 13(8):1015-21. PubMed ID: 24972718
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Damage due to treatment of psoriasis with folic acid antagonists].
    Randazzo SD; Chiarenza A; Lazzaro C
    G Ital Dermatol Minerva Dermatol; 1972 Feb; 47(2):77-81. PubMed ID: 4260377
    [No Abstract]   [Full Text] [Related]  

  • 40. [A case of severe methacycline damage to the liver and bone marrow].
    Khadzhieva Zh; Chernev K; Iordanova E
    Vutr Boles; 1987; 26(6):115-7. PubMed ID: 3439145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.